Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-31

Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating FMX114 vs vehicle in adults with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FMX114

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED